Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05859477
Title Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer (NIVOFGFR2)
Acronym NIVOFGFR2
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Kidney Cancer Research Bureau
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST